Long Ideas - Coronado Biosciences (NASDAQ:CNDO) announced that an investigator-sponsored Phase II clinical trial has begun evaluating the company’s novel immunotherapy in patients with ulcerative colitis (UC). CNDO-201, … Continue Reading
Read nowLong Ideas - The Celsion Corporation (NASDAQ:CLSN) in collaboration with Royal Phillips Electronics (NYSE:PHG) announced this morning that the FDA has approved a Phase II clinical trial of … Continue Reading
Read now- Shares of ViroPharma (NASDAQ:VPHM) are trading higher today after the company announced early this afternoon that the FDA approved its hereditary angioedema treatment Cinryze for … Continue Reading
Read now- Shares of Exelixis (NASDAQ:EXEL) are down 10% already in pre-market trading after the company announced a 20 million share public offering and $225 million principal … Continue Reading
Read now- Israel-based Pluristem (NASDAQ:PSTI) announced that treatment with its Placental eXpanded (PLX) cells saved the life of a cancer patient with pancytopenia, a dangerous reduction in … Continue Reading
Read now- The FDA gave approval on Friday for ten drugmakers to begin marketing generic versions of Singulair, Merck’s (NYSE:MRK) $5B asthma treatment. Investors and analysts have … Continue Reading
Read now- Acorda Therapeutics (NASDAQ:ACOR) is expected to announce trial results for its lead drug Ampyra in a 5mg dose (not an approved strength), which was part … Continue Reading
Read now